Clinical Trial Update: A First in Human Study of ORT247 in Healthy Volunteers [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial of ORT247 in healthy volunteers has completed, evaluating initial safety, tolerability, and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• ORT247 (ORT247)

Snippet

Sponsor: Orthogonal Neuroscience Inc. | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 1 | Status: COMPLETED